Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

200 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical and immunological benefits of full primary COVID-19 vaccination in individuals with SARS-CoV-2 breakthrough infections: A prospective cohort study in non-hospitalized adults.
Prelog M, Jeske SD, Asam C, Fuchs A, Wieser A, Gall C, Wytopil M, Mueller-Schmucker SM, Beileke S, Goekkaya M, Kling E, Geldmacher C, Rubio-Acero R, Plank M, Christa C, Willmann A, Vu M, Einhauser S, Weps M, Lampl BMJ, Almanzar G, Kousha K, Schwägerl V, Liebl B, Weber B, Drescher J, Scheidt J, Gefeller O, Messmann H, Protzer U, Liese J, Hoelscher M, Wagner R, Überla K, Steininger P; CoVaKo Study Group. Prelog M, et al. Among authors: wieser a. J Clin Virol. 2024 Feb;170:105622. doi: 10.1016/j.jcv.2023.105622. Epub 2023 Nov 28. J Clin Virol. 2024. PMID: 38091664
Comparison of Intranasal Outer Membrane Vesicles with Cholera Toxin and Injected MF59C.1 as Adjuvants for Malaria Transmission Blocking Antigens AnAPN1 and Pfs48/45.
Pritsch M, Ben-Khaled N, Chaloupka M, Kobold S, Berens-Riha N, Peter A, Liegl G, Schubert S, Hoelscher M, Löscher T, Wieser A. Pritsch M, et al. Among authors: wieser a. J Immunol Res. 2016;2016:3576028. doi: 10.1155/2016/3576028. Epub 2016 Apr 27. J Immunol Res. 2016. PMID: 27239480 Free PMC article.
Protocol of a population-based prospective COVID-19 cohort study Munich, Germany (KoCo19).
Radon K, Saathoff E, Pritsch M, Guggenbühl Noller JM, Kroidl I, Olbrich L, Thiel V, Diefenbach M, Riess F, Forster F, Theis F, Wieser A, Hoelscher M; KoCo19 collaboration group. Radon K, et al. Among authors: wieser a. BMC Public Health. 2020 Jun 30;20(1):1036. doi: 10.1186/s12889-020-09164-9. BMC Public Health. 2020. PMID: 32605549 Free PMC article.
Publisher Correction to: Protocol of a population-based prospective COVID-19 cohort study Munich, Germany (KoCo19).
Radon K, Saathoff E, Pritsch M, Guggenbühl Noller JM, Kroidl I, Olbrich L, Thiel V, Diefenbach M, Riess F, Forster F, Theis F, Wieser A, Hoelscher M; KoCo19 collaboration group. Radon K, et al. Among authors: wieser a. BMC Public Health. 2020 Sep 1;20(1):1335. doi: 10.1186/s12889-020-09394-x. BMC Public Health. 2020. PMID: 32873261 Free PMC article.
Rapid prototyping vaccine approach in mice against multi-drug resistant Gram-negative organisms from clinical isolates based on outer membrane vesicles.
Pritsch M, Ben Khaled N, Liegl G, Schubert S, Hoelscher M, Woischke C, Arens N, Thorn-Seshold J, Kammermeier S, Wieser A. Pritsch M, et al. Among authors: wieser a. Microbiol Immunol. 2021 May;65(5):214-227. doi: 10.1111/1348-0421.12882. Epub 2021 May 4. Microbiol Immunol. 2021. PMID: 33650163 Free article.
Broad T Cell Targeting of Structural Proteins After SARS-CoV-2 Infection: High Throughput Assessment of T Cell Reactivity Using an Automated Interferon Gamma Release Assay.
Brand I, Gilberg L, Bruger J, Garí M, Wieser A, Eser TM, Frese J, Ahmed MIM, Rubio-Acero R, Guggenbuehl Noller JM, Castelletti N, Diekmannshemke J, Thiesbrummel S, Huynh D, Winter S, Kroidl I, Fuchs C, Hoelscher M, Roider J, Kobold S, Pritsch M, Geldmacher C. Brand I, et al. Among authors: wieser a. Front Immunol. 2021 May 20;12:688436. doi: 10.3389/fimmu.2021.688436. eCollection 2021. Front Immunol. 2021. PMID: 34093595 Free PMC article.
In Search of the SARS-CoV-2 Protection Correlate: Head-to-Head Comparison of Two Quantitative S1 Assays in Pre-characterized Oligo-/Asymptomatic Patients.
Rubio-Acero R, Castelletti N, Fingerle V, Olbrich L, Bakuli A, Wölfel R, Girl P, Müller K, Jochum S, Strobl M, Hoelscher M, Wieser A; KoCo19 study team. Rubio-Acero R, et al. Among authors: wieser a. Infect Dis Ther. 2021 Sep;10(3):1505-1518. doi: 10.1007/s40121-021-00475-x. Epub 2021 Jun 16. Infect Dis Ther. 2021. PMID: 34137000 Free PMC article.
200 results